Literature DB >> 7544789

Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases.

T Yin1, S R Keller, F W Quelle, B A Witthuhn, M L Tsang, G E Lienhard, J N Ihle, Y C Yang.   

Abstract

Interleukin (IL)-9 stimulates the proliferation of a variety of hematopoietic lineages through its interaction with a receptor of the cytokine receptor superfamily. In the studies presented here, we have begun to characterize the downstream signaling pathways activated by IL-9. In addition to the activation of JAK1 and JAK3 tyrosine kinases, IL-9, unlike most hematopoietic cytokines but similar to IL-4, induces the tyrosine phosphorylation of a 170-kDa protein that is related to the insulin receptor substrate-1 (IRS-1). We further demonstrate for the first time that IRS-1 is not only associated with JAK1 but also tyrosine phosphorylated and functionally involved in IL-9 signaling in TS1 lymphocytes transfected with the murine IRS-1 cDNA. Cotransfection studies and in vitro experiments directly demonstrate that JAK1, JAK2, or JAK3 is capable of tyrosine phosphorylating IRS-1, suggesting a functional role for these kinases in vivo. Lastly, we demonstrate that IL-9 induces the tyrosine phosphorylation of Stat3 and in this regard differs from IL-4, which triggers tyrosine phosphorylation of Stat6. Taken together, these results strongly suggest that IL-9 and IL-4 utilize common and unique signaling pathways via inducing the similar and distinct tyrosine-phosphorylated proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544789     DOI: 10.1074/jbc.270.35.20497

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  14-3-3zeta interacts with the alpha-chain of human interleukin 9 receptor.

Authors:  D Sliva; M Gu; Y X Zhu; J Chen; S Tsai; X Du; Y C Yang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Cross-talk between the insulin and angiotensin signaling systems.

Authors:  L A Velloso; F Folli; X J Sun; M F White; M J Saad; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Cloning and functional testing of rhesus macaque (Macaca mulatta) IL-9 and IL-33.

Authors:  Sanghita Sarkar; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  J Med Primatol       Date:  2020-02-04       Impact factor: 0.667

Review 4.  A brief history of IL-9.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2011-03-15       Impact factor: 5.422

Review 5.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

6.  Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections.

Authors:  W I Khan; M Richard; H Akiho; P A Blennerhasset; N E Humphreys; R K Grencis; J Van Snick; S M Collins
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain.

Authors:  H Fujiwara; S H Hanissian; A Tsytsykova; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function.

Authors:  H Ueno; E Kondo; R Yamamoto-Honda; K Tobe; T Nakamoto; K Sasaki; K Mitani; A Furusaka; T Tanaka; Y Tsujimoto; T Kadowaki; H Hirai
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

9.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

10.  Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Authors:  Nicola M Heller; Xiulan Qi; Ilkka S Junttila; Kari Ann Shirey; Stefanie N Vogel; William E Paul; Achsah D Keegan
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.